Begoña Campos Balea (Begoña Campos-Balea, Begoña Campos)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Clinical Practice

Basal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of clinical medicine

OncoTargets and therapy

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mariano Provencio Pulla, Diego Pérez-Parente, Sara Olson, Haroon Hasan, Begoña Campos Balea, Delvys Rodriguez Abreu, Marta López-Brea Piqueras, Navdeep Pal, Samantha V Wilkinson, Esther Vilas, Pedro Ruiz-Gracia, Manuel Cobo
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (6) (2024)
Mariano Provencio Pulla, Diego Pérez-Parente, Sara Olson, Haroon Hasan, Begoña Campos Balea, Delvys Rodriguez Abreu, Marta López-Brea Piqueras, Navdeep Pal, Samantha V Wilkinson, Esther Vilas, Pedro Ruiz-Gracia, Manuel Cobo
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Ivan Marquez-Rodas, Eva Muñoz Couselo, Juan F Rodríguez Moreno, Ana Mª Arance Fernández, Miguel Ángel Berciano Guerrero, Begoña Campos Balea, Luis de la Cruz Merino, Enrique Espinosa Arranz, Almudena García Castaño, Alfonso Berrocal Jaime
SEOM-GEM clinical guidelines for cutaneous melanoma (2023). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Mariano Provencio Pulla, Diego Pérez-Parente, Sara Olson, Haroon Hasan, Begoña Campos Balea, Delvys Rodriguez Abreu, Marta López-Brea Piqueras, Navdeep Pal, Samantha V Wilkinson, Esther Vilas, Pedro Ruiz-Gracia, Manuel Cobo
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (6) (2024)
Mariano Provencio Pulla, Diego Pérez-Parente, Sara Olson, Haroon Hasan, Begoña Campos Balea, Delvys Rodriguez Abreu, Marta López-Brea Piqueras, Navdeep Pal, Samantha V Wilkinson, Esther Vilas, Pedro Ruiz-Gracia, Manuel Cobo
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (6) (2024)
Mariano Provencio Pulla, Diego Pérez-Parente, Sara Olson, Haroon Hasan, Begoña Campos Balea, Delvys Rodriguez Abreu, Marta López-Brea Piqueras, Navdeep Pal, Samantha V Wilkinson, Esther Vilas, Pedro Ruiz-Gracia, Manuel Cobo
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (6) (2024)
Begoña Campos Balea, Ovidio Fernández-Calvo, Roberto García-Figueiras, Carlos Neira, Carmen Peña-Penabad, Carmela Rodríguez-López, Rocío Vílchez-Simo, María Quindós-Varela
Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (8) (2022)
Mª Del Carmen Álamo, Sebastian Ochenduszko, Guillermo Crespo, Mónica Corral, Juana Oramas, Pilar Sancho, Javier Medina, Fernando Garicano, Pedro López, Begoña Campos Balea, Analia Rodríguez Garzotto, Eva Muñoz-Couselo
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. OncoTargets and therapy 14 (2021)
María Rosario García Campelo, Edurne Arriola, Begoña Campos Balea, Marta López-Brea, José Fuentes-Pradera, Javier de Castro Carpeno, Carlos Aguado, Diego Pérez Parente, Fidel de Oro Pulido, Pedro Ruiz-Gracia, Delvys Rodríguez-Abreu
PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis. Journal of clinical medicine 10 (19) (2021)
Maria Gonzales Cao, Clara Mayo de Las Casas, Juana Oramas, Miguel-Angel Berciano-Guerrero, Luis de la Cruz, Pablo Cerezuela, Ana Arance, Eva Muñoz-Couselo, Enrique Espinosa, Teresa Puertolas, Roberto Diaz Beveridge, Sebastian Ochenduszko, Maria-Jose Villanueva, Laura Basterretxea, Lorena Bellido, Delvys Rodriguez, Begoña Campos Balea, Clara Montagut, Ana Drozdowskyj, Miguel Ángel Molina-Vila, Jose Antonio Lopez-Martin, Alfonso Berrocal
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial. Nature communications 12 (1) (2021)
Jorge G González, Juan Ruiz-Bañobre, Francisco J Afonso-Afonso, Margarita Amenedo-Gancedo, María Del Carmen Areses-Manrique, Begoña Campos Balea, Joaquín Casal-Rubio, Natalia Fernández-Núñez, José Luis Fírvida Pérez, Martín Lázaro, Diego Pérez Parente, Leonardo Crama, Pedro Ruiz-Gracia, Lucía Santomé-Couto, Luis León-Mateos
PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis. Journal of clinical medicine 9 (7) (2020)
Begoña Campos Balea, Javier de Castro Carpeño, Bartomeu Massutí, David Vicente-Baz, Diego Pérez Parente, Pedro Ruiz-Gracia, Leonardo Crama, Manuel Cobo Dols
Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database. Thoracic cancer 11 (11) (2020)